Home Tech 18 sci-tech innovation board stocks have annual reports with a loss and...

18 sci-tech innovation board stocks have annual reports with a loss and the first loss after listing

0

As of April 15, 261 companies listed on the Science and Technology Innovation Board have disclosed their main financial data for 2020 in the form of annual reports or performance bulletins. According to Wind data, 18 shares attributable to 2020 including Junshi Bio, Zejing Pharmaceutical, and You Kede are in a state of loss. Among the aforementioned 18 performance-loss stocks, 14 are companies with “U”, and 4 stocks including Ukde have lost money for the first time since they went public.


The net profit attributable to Shengxiang Biological and other companies increased by more than 10 times

According to the data disclosed by Wind, among the 261 listed companies on the Sci-tech Innovation Board, 243 companies will achieve profitable net profits in 2020, accounting for about 93.1% of the number of companies on the Sci-tech Innovation Board.

According to Wind data, among the 243 sci-tech innovation board listed companies, 136 companies will achieve attributable net profit of more than 100 million yuan in 2020. Among them, 17 stocks such as Lanqi Technology, Trina Solar, Stone Technology, and Oriental Bio will be realized in 2020. The net profit attributable to over 1 billion yuan. Judging from the data disclosed by Wind, SMIC’s net profit attributable to 2020 will be approximately 4.332 billion yuan, ranking first in science and technology stocks in terms of profit.

The growth rate of attributable net profit is an important indicator to measure the growth and development capabilities of a company. According to Wind data, among the 243 companies listed on the Sci-tech Innovation Board with attributable net profits in 2020, 180 companies’ attributable net profits in 2020 will increase year-on-year. Among them, 29 stocks including Chipsea Technology, Haier Biotechnology, and Kingsoft Office will be The annual attributable net profit doubled year-on-year, and the attributable net profit of the four sci-tech innovation board listed companies of Shengxiang Bio, Shijia Photonics, Oriental Bio, and Zhijiang Bio will increase by more than 10 times in 2020.

The biggest increase is Shengxiang Biology. The data shows that in 2020, the attributable net profit of Shengxiang Bio will be approximately 2.617 billion yuan, a year-on-year increase of over 65 times. The attributable net profit of Shijia Photonics, Oriental Bio, and Zhijiang Bio will be 39 million yuan, 1.688 billion yuan, and 928 million yuan in 2020, respectively, representing a year-on-year increase of 2542.2%, 1956.37%, and 1701.53% respectively. From the perspective of Wind industry, Shengxiang Bio, Oriental Bio, and Zhijiang Bio are all medical and healthcare companies.

Wind statistics show that among the 243 listed companies on the Science and Technology Innovation Board, there are still many stocks that have seen a year-on-year decline in net profit attributable to 2020. Specifically, the net profit attributable to 24 shares in 2020 has declined by more than 30% year-on-year, including Espressif Technology, Minxin, Haohaishengke, etc. The net profit attributable to 5 stocks including Shin Kong Optoelectronics, Sino Medical, Nuohe Zhiyuan, Ruisheng Intelligent, and Tianyi Shangjia will drop by more than 50% in 2020.

The net profit attributable to 14 shares exceeded 100 million yuan

According to Wind data, there are 18 sci-tech innovation board listed companies in a state of loss in 2020 attributable net profits.

Specifically, among the 18 companies listed on the Science and Technology Innovation Board, 14 stocks will have attributable net profit losses exceeding 100 million yuan in 2020, including Qingyun Technology, Frontier Biology, and Zejing Pharmaceuticals.

The data disclosed by Wind shows that among the 18 sci-tech innovation board listed companies that have attributable net profit losses in 2020, Junshi Biologics has the largest amount of losses. The data shows that Junshi Bio will have a net profit loss of approximately 1.669 billion yuan in 2020.

It is understood that Junshi Biotech was listed on July 15, 2020 and is an innovation-driven biopharmaceutical company. Regarding the reason for the performance loss, Junshi Biotech stated that it was mainly because the company’s operating income could not fully cover the continuously increasing R&D investment in research projects and reserve R&D projects. Junshi Bio also stated that the company reserves a number of research projects in the early preclinical research stage, and the company will continue to invest in large-scale research and development in the future to complete preclinical research, clinical trials and preparations for new drugs. The company’s product pipeline research and development business, and the company’s new drug listing application and new drug market promotion will also incur high costs, which may lead to further expansion of the company’s losses.

After Junshi Biologics is Shenzhou Cell, the company’s attributable net profit loss in 2020 is about 713 million yuan.

It is worth mentioning that according to Wind data statistics, among the 18 sci-tech innovation board listed companies that have a net profit loss in 2020, 14 are companies with “U”, accounting for about the proportion of the number of companies with a net profit loss in 2020. 77.78%.

According to the industry to which Wind belongs, among the 18 sci-tech innovation board listed companies that will have a net profit loss in 2020, 9 companies including Junshi Bio, Shenzhou Cell, Biotech, and Kangsino belong to the healthcare industry. Qingyun Technology, Youke Six companies, including Deer, Cambrian, etc., belong to the information technology industry, while three companies, Funeng Technology, Eft, and Yihuatong, belong to the industrial field.

Song Qinghui, a well-known economist, believes that most of the companies with performance losses in the science and technology board stocks are biomedical innovation companies. From the perspective of the general development cycle, the large R&D investment before the product launches, and the situation of sustained losses or even no income in the short term is the inevitable pain for the growth of these companies.

4 shares are now listed for the first loss

It is worth noting that the 4 shares of You Kede, Funeng Technology, Sansheng Guojian, and Youfang Technology will usher in their first losses on the market.

Excluding the companies with “U”, among the 18 sci-tech innovation board listed companies with a net profit loss in 2020, Youqo will have the worst performance. According to the 2020 performance bulletin disclosed by Youkede, in 2020, Youkede realized operating income of approximately 2.466 billion yuan, a year-on-year increase of 62.79%; the corresponding realized net profit loss was approximately 341 million yuan, which turned from profit to loss year-on-year.

It is understood that Ukerde was listed on January 20, 2020. It is a third-party cloud computing service provider and one of the first companies to pass the certification of trusted cloud services. It adopts three modes: public cloud, private cloud, and hybrid cloud. Users provide services. This is also the first loss in the annual report of Ukde since its listing.

Regarding the specific reasons for the company’s 2020 attributable net profit loss, a relevant person of Youkede said in an interview with a reporter from Beijing Business Daily, “We are currently in the silent period of annual reports. The 2020 annual report will be issued on April 27. The matter will be explained in detail”.

In addition to You Kede, Funeng Technology, Sansheng Guojian, and Youfang Technology also experienced their first losses on the market. It is understood that Sansheng Guojian went public on July 22, 2020, and is mainly engaged in the research and development, production and sales of antibody drugs. The performance bulletin shows that Sansheng Guojian will have a net profit loss of about 200 million yuan in 2020. Before listing, 3SBio Group maintained its profitability in its performance. Data show that from 2017 to 2019, the attributable net profit of Sansheng Guojian was approximately 390 million yuan, 370 million yuan, and 230 million yuan, respectively.

Funeng Technology and Youfang Technology were listed on July 17, 2020 and January 23, 2020 respectively. The net profit attributable to Funeng Technology and Youfang Technology in 2020 will be approximately -316 million yuan and -69 million yuan, respectively.

Xu Xiaoheng, an investment and financing expert, said that investors should be cautious in investing in stocks that have “changed their faces” after listing.

Beijing Commercial Daily reporter Liu Fengru

NO COMMENTS